Patents by Inventor Clive Leighton Bunn

Clive Leighton Bunn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PAI-2 conjugates for the treatment and imaging of cancer
    Patent number: 7998934
    Abstract: A method is described for detecting, visualizing, or treating cells, particularly cancerous cells, that express a uPA/uPAR complex. The method employs a PAI-2 conjugate molecule that comprises PAI-2 or a functional derivative, homologue, analogue, chemical equivalent or mimetic thereof, which PAI-2 is bound, linked, or otherwise associated with a toxin or label.
    Type: Grant
    Filed: October 14, 2008
    Date of Patent: August 16, 2011
    Assignees: PAI-2 Pty Limited, University of Wollongong, Medical Scitec Australia Pty Ltd.
    Inventors: Marie Ranson, Barry John Allen, Clive Leighton Bunn
  • PAI-2 conjugates for the treatment and imaging of cancer
    Patent number: 7547441
    Abstract: A method is described for detecting, visualizing, or treating cells, particularly cancerous cells, that express a uPA/uPAR complex. The method employs a PAI-2 conjugate molecule that comprises PAI-2 or a functional derivative, homologue, analogue, chemical equivalent or mimetic thereof, which PAI-2 is bound, linked, or otherwise associated with a toxin or label.
    Type: Grant
    Filed: February 23, 2001
    Date of Patent: June 16, 2009
    Assignees: PAI-2 Pty Limited, University of Wollongong, Medical Scitec Australia Pty Ltd
    Inventors: Marie Ranson, Barry John Allen, Clive Leighton Bunn
  • PAI-2 conjugates for the treatment and imaging of cancer
    Publication number: 20090136421
    Abstract: A method is described for detecting, visualizing, or treating cells, particularly cancerous cells, that express a uPA/uPAR complex. The method employs a PAI-2 conjugate molecule that comprises PAI-2 or a functional derivative, homologue, analogue, chemical equivalent or mimetic thereof, which PAI-2 is bound, linked, or otherwise associated with a toxin or label.
    Type: Application
    Filed: October 14, 2008
    Publication date: May 28, 2009
    Inventors: Marie Ranson, Barry John Allen, Clive Leighton Bunn
  • Use of protease inhibitors for treating skin wounds
    Patent number: 6344189
    Abstract: The healing of chronic wounds, such as leg ulcers, is accelerated via topical administration of a serine protease inhibitor, such as PAI-2. Wound healing also is promoted using combinations of protease inhibitors, such as PAI-2 with other serine protease inhibitors and/or with protease inhibitors such inhibitors of metalloproteinases, acid proteases, and thiol proteases, respectively.
    Type: Grant
    Filed: November 13, 1998
    Date of Patent: February 5, 2002
    Assignee: Biotech Australia Pty., Ltd.
    Inventors: Clive Leighton Bunn, John Lewis Andrews, Phillip John Sharp
  • PAI-2 conjugates for the treatment and imaging of cancer
    Publication number: 20020002134
    Abstract: A method is described for detecting, visualizing, or treating cells, particularly cancerous cells, that express a uPA/uPAR complex. The method employs a PAI-2 conjugate molecule that comprises PAI-2 or a functional derivative, homologue, analogue, chemical equivalent or mimetic thereof, which PAI-2 is bound, linked, or otherwise associated with a toxin or label.
    Type: Application
    Filed: February 23, 2001
    Publication date: January 3, 2002
    Inventors: Marie Ranson, Barry John Allen, Clive Leighton Bunn
  • Protease inhibitors for use in the treatment of psoriasis
    Patent number: 6288025
    Abstract: Psoriasis may be treated by topical administration of a urokinase inhibitor, such as PAI-2, or a combination of protease inhibitors, such as PAI-2 with other serine protease inhibitors and/or with protease inhibitors such as inhibitors of metalloproteinases, acid proteases, and thiol proteases.
    Type: Grant
    Filed: August 5, 1999
    Date of Patent: September 11, 2001
    Assignee: Biotech Australia Pty Limited
    Inventors: Clive Leighton Bunn, Phillip John Sharp